Back

Impact of type 2 diabetes on the incidence of cardiorenal syndromes and on subsequent clinical outcomes: a propensity-matched nationwide analysis.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: The comorbid complexity of heart failure Comorbidities ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Laurent Fauchier

University Hospital of Tours, Tours (France)

5 More presentations in this session

Presentation thumbnail
Impact of prediabetes and type 2 diabetes mellitus on cardiac function in the general population
Doctor V. Schmitt (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Coexistence of sarcopenia and osteoporosis in patients with heart failure: prevalence and association with functional status
Mr R. Numazawa (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Prediction of mortality and mode of death in heart failure using multimorbidity and clinical risk score systems: a nationwide analysis
Professor L. Fauchier (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Loss of social role awareness, a subdomain of social frailty, is an independent predictor of future adverse events in hospitalized older patients with heart failure
Mr S. Katano (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Verification of the impact of the improvement and worsening of anemia after discharge of heart failure on cardiorenal nutrition and the prognosis of HFpEF from the PURSUIT-HFpEF registry
Doctor T. KITAO (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
The comorbid complexity of heart failure

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Cardio-renal syndromes in patients admitted with ST-elevation myocardial infarctions: Incidence and impact on renal and overall outcome
thumbnail
Congress Presentation
Beyond a passing decline: acute cardiorenal syndrome as a marker of true renal dysfunction
thumbnail
Congress Presentation
Treatment of cardiovascular comorbidities in patients with heart failure - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources